Friday, 26 Sep 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    बिग बॉस 19 एपिसोड 32: जबरदस्त टकराव, टूटी दोस्तियां और चौंकाने वाला मोड़!
    बिग बॉस 19 एपिसोड 32: जबरदस्त टकराव, टूटी दोस्तियां और चौंकाने वाला मोड़!
    25/09/2025
    Bigg Boss 19 Episode 32: Explosive Clashes, Broken Friendships and a Shocking Twist!
    Bigg Boss 19 Episode 32: Explosive Clashes, Broken Friendships and a Shocking Twist!
    25/09/2025
    Abu Dhabi Autonomous Summit to define the future of smart mobility as part of Abu Dhabi Autonomous Week 2025
    Abu Dhabi Autonomous Summit to define the future of smart mobility as part of Abu Dhabi Autonomous Week 2025
    25/09/2025
    VESTIAIRE COLLECTIVE RELEASES FIRST MENSWEAR RESALE REPORT AS PART OF ITS MEN’S CATEGORY LAUNCH
    VESTIAIRE COLLECTIVE RELEASES FIRST MENSWEAR RESALE REPORT AS PART OF ITS MEN’S CATEGORY LAUNCH
    25/09/2025
    Bigg Boss 19 Review Explosive Fights, Shocking Nominations & Abhishek’s Captaincy | Episode Analysis
    Bigg Boss 19 Review Explosive Fights, Shocking Nominations & Abhishek’s Captaincy | Episode Analysis
    25/09/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • today
  • announced
  • july
  •  and
  •  the
  • Tech
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.

PRNW Agency
Last updated: 10/06/2025 7:52 PM
PRNW Agency
Share
4 Min Read
Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.
SHARE
Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.

- Advertisement -

FREMONT, Calif., June 10, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer’s Disease Data Initiative and Gates Ventures today announced a strategic partnership with the goal to generate one of the largest proteomic datasets linked to clinical outcomes in Alzheimer’s Disease (AD). This international project will profile over 40,000 plasma samples representing AD and related dementias using Alamar’s ultra-sensitive NULISA™ technology, with the goal of accelerating biomarker discovery and driving new insights into the progression and treatment of AD.

- Advertisement -

“This collaboration reflects our shared commitment to transform the landscape of Alzheimer’s research through data, technology, and global partnerships,” said Yuling Luo, PhD, Founder, Chairman and CEO of Alamar Biosciences. “By combining our NULISA platform with Alzheimer’s Disease Data Initiative’s infrastructure and Gates Venture’s mission-driven investment, we aim to catalyze a new era of biomarker-driven discovery and therapeutic development.”

As part of the initiative, Alamar’s NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 will be implemented at research centers in the United States, Sweden, United Kingdom, and India. These panels deliver unparalleled sensitivity and specificity, enabling the accurate measurement of hundreds of brain- and immune-related proteins from just a small volume of blood or cerebrospinal fluid. A key feature of the CNS panel is its unique ability to distinguish brain-derived phosphorylated tau from total phosphorylated tau in blood—a critical advancement for the development of community-based screening programs. The resulting proteomic data will be integrated with clinical and longitudinal outcome measures and shared with the global research community by leveraging the Global Neurodegeneration Proteomics Consortium‘s (GNPC) secure data-sharing processes.

- Advertisement -

“Understanding the biological underpinnings of Alzheimer’s Disease is essential for developing effective treatments,” said Niranjan Bose, Managing Director of Health & Life Sciences at Gates Ventures and interim Executive Director of the Alzheimer’s Disease Data Initiative. “This initiative will provide a rich resource to researchers worldwide and help overcome long-standing barriers in early detection and stratified interventions.”

- Advertisement -

This initiative represents a major step forward in building a comprehensive, clinically annotated Alzheimer’s plasma proteome atlas, with the potential to unlock new biomarkers for diagnosis, prognosis, and therapeutic response. This strategic collaboration complements the efforts of the GNPC, which has brought together top dementia researchers and datasets to collaborate and create one of the largest disease-specific proteomics datasets ever assembled. The project also emphasizes inclusivity by incorporating diverse cohorts from multiple geographic and ethnic populations.

About the Alzheimer’s Disease Data Initiative
The Alzheimer’s Disease Data Initiative is a coalition of leading academic, advocacy, government, industry, and philanthropy organizations that recognizes the need for dementia researchers to find easier ways to share data, analytical tools, and scientific findings. These partners are working together to accelerate progress towards new diagnostics, treatments, and cures for Alzheimer’s disease and related dementias. Learn more about the Alzheimer’s Disease Data Initiative at www.alzheimersdata.org.

- Advertisement -

About Alamar Biosciences, Inc.

- Advertisement -

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com

 

- Advertisement -

Logo – https://mma.prnewswire.com/media/1810182/Alamar_Logo_WhiteOutline_RGB_4x1_Logo_V1.jpg
Logo – https://mma.prnewswire.com/media/2707122/Alzheimers_Disease_Data_Initiative_Logo.jpg
Logo – https://mma.prnewswire.com/media/2707123/Gates_Ventures_Logo.jpg 

- Advertisement -

 

View original content:https://www.prnewswire.co.uk/news-releases/alamar-biosciences-alzheimers-disease-data-initiative-and-gates-ventures-unite-in-global-partnership-to-advance-translational-research-in-alzheimers-disease-302477745.html

- Advertisement -
2025 GENESIS SCOTTISH OPEN TEES UP ICONIC PLAYERS AND EXHILARATING FAN EXPERIENCES
Elion Launches Integration of Coalition for Health AI Nutrition Label Within Vendor Marketplace
Utah’s Ruth and Nathan Hale Theater Enthralling Audiences with Modern Elation Lighting
Hoardsun Tech Group Chairman: Powering BRICS AI Growth through AI Optoelectronics
Philip Morris International’s India Affiliate Reiterates its Commitment to ‘Grow Talent, Grow Business’
TAGGED:alamaralzheimersbiosciencescalifcompanydatadetectiondiscoverydiseaseearliestenablefremontgatesgoalinitiativejunemulticenternulisa™poweringprecisionprofileprojectproteomicssamplesTechnologytodayultrasensitiveusingventureswill
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

NEXEN TIRE Unveils NFERA Supreme EV ROOT Bridging EV and ICE with One Universal Fit

06/08/2025
Tigo Energy Highlights 4.3MW Optimized Rapid Shutdown Project at Intersolar 2025 in Brazil
Business

Tigo Energy Highlights 4.3MW Optimized Rapid Shutdown Project at Intersolar 2025 in Brazil

19/08/2025
Imaging Endpoints Announces Patent Application for AI Review Charter System
Health

Imaging Endpoints Announces Patent Application for AI Review Charter System

11/09/2025
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
Business

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

15/08/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?